28 Apr 2020 --- Better vitamin K status in patients with COVID-19 has been linked to improved health outcomes, compared to patients with poor vitamin K status. The research, published in the journal Preprints, suggests a connection between low levels of vitamin K and the accelerated breakdown of tissue fibers, including elastin, which is involved with pulmonary disease. Patients with severe COVID-19 are more likely to have comorbidities such as Type 2 diabetes, hypertension and cardiovascular diseases (CVD), which are also associated with reduced vitamin K status. The findings suggest that improved vitamin K levels may play a role in improving the body’s natural ability to cope with the novel virus. However, researchers warn that more studies are warranted before any real conclusions can be drawn.
